GAMA MEDICALS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
GAMA MEDICALS
Largest movements
- Tangible fixed assets -€113,341
down €113,341 (-41.3%), from €274,455 to €161,114
of which Furniture and vehicles: -€69,614
- Stocks and contracts -€21,381
down €21,381 (-10.0%), from €214,497 to €193,116
- Deferred charges and accrued income +€8,872
up €8,872 (+1,437%), from €617 to €9,489
- Cash -€7,500
down €7,500 (-13.0%), from €57,864 to €50,364
mainly Debts after one year (-€73,423) and Trade debts (-€64,148)
- Debts after one year -€73,423
down €73,423 (-42.6%), from €172,267 to €98,844
- Trade debts -€64,148
down €64,148 (-19.7%), from €325,473 to €261,326
- Profit (loss) carried forward +€30,235
up €30,235 (+216%), from €14,005 to €44,240
- Current portion of long-term debt -€24,274
down €24,274 (-44.3%), from €54,772 to €30,497
- Other debts -€8,947
no longer reported in 2025 (was €8,947)
- Depreciation -€37,007
down €37,007 (-34.9%), from €106,135 to €69,128
- Gross operating margin +€28,406
up €28,406 (+9.0%), from €314,927 to €343,333
- Taxes +€7,875
up €7,875 (+4,922%), from €160 to €8,035
- Financial charges -€7,099
down €7,099 (-54.2%), from €13,102 to €6,003
- Staff costs -€4,633
down €4,633 (-2.0%), from €232,614 to €227,980
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €728,193 | €595,368 | -€132,825 | -18.2% |
| Fixed assets | 21/28 | €280,955 | €161,114 | -€119,841 | -42.7% |
| Intangible fixed assets | 21 | €6,500 | - | -€6,500 | |
| Tangible fixed assets | 22/27 | €274,455 | €161,114 | -€113,341 | -41.3% |
| Land and buildings | 22 | €2,246 | €938 | -€1,309 | -58.3% |
| Plant, machinery and equipment | 23 | €107,263 | €68,010 | -€39,253 | -36.6% |
| Furniture and vehicles | 24 | €79,605 | €9,991 | -€69,614 | -87.4% |
| Other tangible fixed assets | 26 | €85,341 | €82,175 | -€3,166 | -3.7% |
| Current assets | 29/58 | €447,238 | €434,254 | -€12,984 | -2.9% |
| Stocks and contracts in progress | 3 | €214,497 | €193,116 | -€21,381 | -10.0% |
| Stocks | 30/36 | €214,497 | €193,116 | -€21,381 | -10.0% |
| Amounts receivable within one year | 40/41 | €174,260 | €181,285 | +€7,026 | +4.0% |
| Trade receivables | 40 | €141,498 | €139,605 | -€1,893 | -1.3% |
| Other amounts receivable | 41 | €32,762 | €41,680 | +€8,919 | +27.2% |
| Cash at bank and in hand | 54/58 | €57,864 | €50,364 | -€7,500 | -13.0% |
| Deferred charges and accrued income | 490/1 | €617 | €9,489 | +€8,872 | +1,437% |
| Total equity and liabilities | 10/49 | €728,193 | €595,368 | -€132,825 | -18.2% |
| Equity | 10/15 | €82,205 | €112,440 | +€30,235 | +36.8% |
| Contributions | 10/11 | €62,000 | €62,000 | = | 0.0% |
| Capital | 10 | €62,000 | €62,000 | = | 0.0% |
| Issued capital | 100 | €62,000 | €62,000 | = | 0.0% |
| Reserves | 13 | €6,200 | €6,200 | = | 0.0% |
| Non-distributable reserves | 130/1 | €6,200 | €6,200 | = | 0.0% |
| Legal reserve | 130 | €6,200 | €6,200 | = | 0.0% |
| Profit (loss) carried forward | 14 | €14,005 | €44,240 | +€30,235 | +216% |
| Amounts payable | 17/49 | €645,988 | €482,928 | -€163,060 | -25.2% |
| Amounts payable after more than one year | 17 | €172,267 | €98,844 | -€73,423 | -42.6% |
| Financial debts | 170/4 | €172,267 | €98,844 | -€73,423 | -42.6% |
| Amounts payable within one year | 42/48 | €473,721 | €384,084 | -€89,637 | -18.9% |
| Current portion of amounts payable after more than one year | 42 | €54,772 | €30,497 | -€24,274 | -44.3% |
| Financial debts | 43 | €50,000 | €55,789 | +€5,789 | +11.6% |
| Credit institutions | 430/8 | €50,000 | €55,789 | +€5,789 | +11.6% |
| Trade debts | 44 | €325,473 | €261,326 | -€64,148 | -19.7% |
| Suppliers | 440/4 | €325,473 | €261,326 | -€64,148 | -19.7% |
| Taxes, remuneration and social security | 45 | €34,529 | €36,472 | +€1,943 | +5.6% |
| Taxes | 450/3 | €2,691 | €5,330 | +€2,639 | +98.1% |
| Remuneration and social security | 454/9 | €31,838 | €31,142 | -€696 | -2.2% |
| Other amounts payable | 47/48 | €8,947 | - | -€8,947 | |
| Remuneration, social security and pensions | 62 | €232,614 | €227,980 | -€4,633 | -2.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €106,135 | €69,128 | -€37,007 | -34.9% |
| Other operating charges | 640/8 | - | €1,960 | +€1,960 | |
| Gross operating margin | 9900 | €314,927 | €343,333 | +€28,406 | +9.0% |
| Operating profit (loss) | 9901 | -€23,822 | €44,265 | +€68,087 | |
| Financial income | 75/76B | - | €7 | +€7 | |
| Recurring financial income | 75 | - | €7 | +€7 | |
| Financial charges | 65/66B | €13,102 | €6,003 | -€7,099 | -54.2% |
| Recurring financial charges | 65 | €13,102 | €6,003 | -€7,099 | -54.2% |
| Profit (loss) for the period before taxes | 9903 | -€36,924 | €38,270 | +€75,193 | |
| Income taxes | 67/77 | €160 | €8,035 | +€7,875 | +4,922% |
| Profit (loss) for the period | 9904 | -€37,084 | €30,235 | +€67,319 | |
| Profit (loss) for the period to be appropriated | 9905 | -€37,084 | €30,235 | +€67,319 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 22 October 2026 via checked.be.